Furthermore, to confirm tumor antigen-specific T cell responses rather than nonspecific T cells activation, we stimulated tumor-derived single cells with either DMSO or gp100, a B16 tumor-associated antigen, then assessed IFNγ-producing CD8+ T cells. This evidence concerns the gene CD8A and neoplasm.